I don't think there are any important contraindications with these molecules. If he gets much worse we might see them add leronlimab to the cocktail which is probably better at severe symptoms and definitely has the safest profile.

Remember too, CYDY is expected to be doing a "long hauler" study to see if leronlimab can be helpful with brain fog, blood clots etc. They have a waiting list of patients waiting to enroll once the protocol is approved.